» Factor IX Inhibitor Plasma Weak Control

ROUTINE INHIBITOR ASSAYS FACTOR IX INHIBITOR CONTROLS

Factor IX Inhibitor Plasma Weak Control

Chronometric assay

Factor IX deficient plasma pool containing an anti-IX inhibitor.

Factor IX Inhibitor Weak Control plasma is frozen human hemophilia B plasma with the addition of anti-FIX inhibitor. This plasma has FIX activity <1% .

Reference	Presentation	Packaging
6-1900-ID	Vial	25 x 0.5 mL

The Safety Data Sheets and Notices are accessible to our registered customers.

Treatment for hemophilia B involves injecting the missing Factor IX I.V. to prevent or stop bleeding. A majority of the complications of this treatment are the development of antibodies against FIX, called inhibitors.
The development of an anti-FIX inhibitor leads to episodes of bleeding that are difficult to control. The activity of the inhibitor is measured by a Bethesda test and is expressed in BU. 1BU neutralizes 50% of the activity of FIX for hemophilia B.

All other coagulation factors have normal values. The title expressed in Bethesda Unit is indicated on each box. Control titrated to the cut-off value according to HAS recommendations.

- 25 cryotubes x 0.5 mL of frozen plasma

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.

ROUTINE INHIBITOR ASSAYS FACTOR IX INHIBITOR CONTROLS

Factor IX Inhibitor Plasma Weak Control

Chronometric assay

The Safety Data Sheets and Notices are accessible to our registered customers.

Cryopep Thrombosis Haemostasis Catalogue 2022

Cryopep Haemostasis Research Catalogue 2022

Product sheet Factor IX Inhibitor Plasma Weak Control

T-TAS® 01 New

BAPA Tube T-TAS® 01 New

You must identify yourself to search for a certificate of analysis

Factor IX Inhibitor Plasma Weak Control

Chronometric assay

Product sheet

The Safety Data Sheets and Notices are accessible to our registered customers.